Izotropic Corporation (IZOZF)
USD 0.03
(-10.45%)
USD 0.03
(-10.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 232.37 Thousand CAD | -47.44% |
| 2023 | 442.11 Thousand CAD | -80.52% |
| 2022 | 2.26 Million CAD | -51.59% |
| 2021 | 4.68 Million CAD | 503.01% |
| 2020 | 777.21 Thousand CAD | 129.23% |
| 2019 | 339.05 Thousand CAD | -31.03% |
| 2018 | 491.63 Thousand CAD | 228.44% |
| 2017 | 149.68 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 342.44 Thousand CAD | -7.82% |
| 2024 Q4 | 232.37 Thousand CAD | -32.14% |
| 2024 FY | 232.37 Thousand CAD | -47.44% |
| 2024 Q2 | 371.5 Thousand CAD | -14.74% |
| 2024 Q1 | 435.75 Thousand CAD | -1.44% |
| 2023 Q1 | 1.82 Million CAD | -19.68% |
| 2023 Q3 | 790.13 Thousand CAD | -31.94% |
| 2023 Q2 | 1.16 Million CAD | -36.29% |
| 2023 FY | 442.11 Thousand CAD | -80.52% |
| 2023 Q4 | 442.11 Thousand CAD | -44.05% |
| 2022 Q2 | 2.81 Million CAD | -33.25% |
| 2022 Q4 | 2.26 Million CAD | 42.84% |
| 2022 FY | 2.26 Million CAD | -51.59% |
| 2022 Q1 | 4.22 Million CAD | -9.95% |
| 2022 Q3 | 1.58 Million CAD | -43.61% |
| 2021 Q1 | 370.05 Thousand CAD | -52.39% |
| 2021 FY | 4.68 Million CAD | 503.01% |
| 2021 Q3 | 5.13 Million CAD | 20.89% |
| 2021 Q4 | 4.68 Million CAD | -8.66% |
| 2021 Q2 | 4.24 Million CAD | 1046.91% |
| 2020 FY | 777.21 Thousand CAD | 129.23% |
| 2020 Q4 | 777.21 Thousand CAD | 185.4% |
| 2020 Q3 | 272.31 Thousand CAD | 84.31% |
| 2020 Q2 | 147.75 Thousand CAD | -52.37% |
| 2020 Q1 | 310.23 Thousand CAD | -8.5% |
| 2019 FY | 339.05 Thousand CAD | -31.03% |
| 2019 Q2 | 530.28 Thousand CAD | -3.74% |
| 2019 Q4 | 339.05 Thousand CAD | -24.47% |
| 2019 Q1 | 550.9 Thousand CAD | 12.06% |
| 2019 Q3 | 448.91 Thousand CAD | -15.35% |
| 2018 Q3 | 603.35 Thousand CAD | -7.68% |
| 2018 Q2 | 653.55 Thousand CAD | 0.0% |
| 2018 Q4 | 491.63 Thousand CAD | -18.52% |
| 2018 FY | 491.63 Thousand CAD | 228.44% |
| 2018 Q1 | - CAD | -100.0% |
| 2017 FY | 149.68 Thousand CAD | 0.0% |
| 2017 Q4 | 149.68 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | 81.688% |
| Arrayit Corporation | 1 Million USD | 76.771% |
| Atlantic International Corp. | 4.43 Million USD | 94.762% |
| Biocept, Inc. | 30.87 Million USD | 99.247% |
| Bioqual, Inc. | 56.58 Million USD | 99.589% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -0.191% |
| DermTech, Inc. | 121.93 Million USD | 99.809% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.994% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 98.693% |
| iMD Companies, Inc. | 190.13 Thousand USD | -22.215% |
| IDenta Corp. | 1.52 Million USD | 84.805% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 98.215% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 97.184% |
| InVitro International | 1.53 Million USD | 84.852% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 99.134% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -9950.865% |
| Medical Imaging Corp. | 4.19 Million USD | 94.456% |
| NovelStem International Corp. | 2.25 Million USD | 89.693% |
| Optigenex Inc. | 1.88 Million USD | 87.694% |
| PharmChem, Inc. | 2.76 Million USD | 91.598% |
| Proteome Sciences plc | 14.58 Million USD | 98.407% |
| Response Genetics, Inc | 48.88 Million USD | 99.525% |
| Rennova Health, Inc. | 20.57 Million USD | 98.87% |
| RushNet, Inc. | 6.04 Million USD | 96.158% |
| ScreenPro Security Inc. | 1.26 Million USD | 81.577% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | 50.812% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | 66.834% |
| Todos Medical Ltd. | 15.26 Million USD | 98.478% |